A range of new updates have been made to the TGA Medicine Shortages Information page
There have been a number of new updates posted on the Therapeutic Goods Administration’s Medicines Shortages Information page.
This webpage provides information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
Among the new anticipated shortage listings are:
- Nyxoid naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial – with a critical shortage anticipated from 27 May due to an unexpected increase in demand
- Minims Prednisolone Sodium Phosphate 0.5% 5mg/mL eye drops ampoule – a critical shortage from 1 June due to manufacturing issues
- Dilantin Paediatric Suspension phenytoin 30mg/5mL oral liquid bottle – with a shortage from 21 May to 13 July for undisclosed reasons
Meanwhile, recent updates also have included notification of resolved shortages for (among other products):
- Aspen Fentanyl fentanyl (as citrate) 100 microgram/2 mL solution for injection – resolved from 15 May
- Epipen Jr adrenaline (epinephrine) 0.15mg/0.3mL injection syringe auto-injector – resolved from 14 May
- Neo-Mercazole carbimazole 5mg tablet bottle – resolved from 7 May
- Eltroxin levothyroxine sodium 25 microgram tablet bottle – resolved from 14 May